• Latest Posts

Pfizer kicks $25M into CellCentric 

FDA gives Orphan Drug Designation to CellCentric multiple myeloma drug

CellCentric receives FDA Fast Track designation for relapsed refractory multiple myeloma drug

In Depth 1 Feb 2023

Cancer: what are the barriers to research?

In Depth 1 Feb 2023

How can cancer care be improved?

Beyond Biotech podcast 26: CellCentric, MicrofluidX, Potter Clarkson